Secretary Jinshan Chen inspected the BIBO Pharma’s Lingang Project on the spot

Time: 2022-11-10  /  View: 562 times

On October 26, 2022, Jinshan Chen, Member of the Standing Committee of the Shanghai Municipal Party Committee, Secretary of the Party Working Committee of the Lingang New Area, Director of the Management Committee and Guohua Yuan, Xiaohua Wu, Deputy Secretaries of the Party Working Committee of the Lingang New Area, and the responsible comrades of the Lingang Management Committee came to visit Lingang Blue Bay for research, and visit the BiBo Pharma’s Lingang project on site.

Peng Jiao, CEO of BiBo Pharma, introduced the project of BiBo Lingang Phase I (P02) and the progress of BiBo Lingang Phase II (P03) to Secretary Jinshan Chen and his party. BiBo Pharma is the core enterprise supported by the major special projects of strategic emerging industries in Shanghai, and the first CDMO enterprise in China dedicated to the large-scale commercial production of biological drugs. BiBo Lingang Phase I (P02) project is China's first full-tech integrated biopharmaceutical GMP production platform. BiBo Lingang Phase II (P03) project is building the world's first single-tank 30,000-liter mammalian cell production base. The project is progressing smoothly at present, and the hoisting of the 30,000-liter stainless steel bioreactor will be held in November. The reactor is the world's first, the world's largest single-tank volume, and has completely independent intellectual property rights. It is the core equipment of BiBo Pharma-Lingang Phase II project. At present, the BiBo P03 project has locked the first overseas production order based on a production capacity of 30,000 liters, and will be put into commercial production in the second half of 2023.